{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:33:20Z","timestamp":1794375200147,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473398"],"award-info":[{"award-number":["82473398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-HR2018-319"],"award-info":[{"award-number":["Y-HR2018-319"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-L2017-002"],"award-info":[{"award-number":["Y-L2017-002"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-JS2019-009"],"award-info":[{"award-number":["Y-JS2019-009"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54710-3","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:30:20Z","timestamp":1732620620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Yu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5098-1172","authenticated-orcid":false,"given":"Yupeng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-322X","authenticated-orcid":false,"given":"Xuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9699-8340","authenticated-orcid":false,"given":"Ao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-5542","authenticated-orcid":false,"given":"Longqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-6159","authenticated-orcid":false,"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-0428","authenticated-orcid":false,"given":"Rongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"54710_CR1","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1007\/s12325-019-01051-z","volume":"36","author":"S Arora","year":"2019","unstructured":"Arora, S. et al. Existing and emerging biomarkers for immune checkpoint immunotherapy in solid tumors. Adv. Ther. 36, 2638\u20132678 (2019).","journal-title":"Adv. Ther."},{"key":"54710_CR2","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9, T. et al. Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N. Engl. J. Med. 383, 2207\u20132218 (2020).","journal-title":"N. Engl. J. Med."},{"key":"54710_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"54710_CR4","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"54710_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S2468-1253(22)00439-3","volume":"8","author":"G Chen","year":"2023","unstructured":"Chen, G. et al. Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. Lancet Gastroenterol. Hepatol. 8, 422\u2013431 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"54710_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566\u2013576 (2020).","journal-title":"Nat. Med"},{"key":"54710_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.biopha.2018.11.105","volume":"110","author":"N Yaghoubi","year":"2019","unstructured":"Yaghoubi, N., Soltani, A., Ghazvini, K., Hassanian, S. M. & Hashemy, S. I. PD-1\/ PD-L1 blockade as a novel treatment for colorectal cancer. Biomed. Pharmacother. 110, 312\u2013318 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"54710_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-020-00377-3","volume":"6","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduct. Target Ther. 6, 4 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"54710_CR9","doi-asserted-by":"publisher","unstructured":"Ho, W. W. et al. Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy. Proc. Natl. Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2105323118 (2021).","DOI":"10.1073\/pnas.2105323118"},{"key":"54710_CR10","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752.e4720 (2021).","journal-title":"Cell"},{"key":"54710_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat. Commun. 13, 1\u201320 (2022).","journal-title":"Nat. Commun."},{"key":"54710_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.fmre.2022.01.036","volume":"3","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. Spatial transcriptome unveils a discontinuous inflammatory pattern in proficient mismatch repair colorectal adenocarcinoma. Fundam. Res. 3, 640\u2013646 (2023).","journal-title":"Fundam. Res."},{"key":"54710_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & Van Eck, N. J. From Louvain to Leiden: Guaranteeing well-connected communities. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"54710_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","volume":"54","author":"I Joanito","year":"2022","unstructured":"Joanito, I. et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat. Genet. 54, 963\u2013975 (2022).","journal-title":"Nat. Genet"},{"key":"54710_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6662","volume":"5","author":"K Shen","year":"2014","unstructured":"Shen, K. et al. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays. Nat. Commun. 5, 5662 (2014).","journal-title":"Nat. Commun."},{"key":"54710_CR16","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li, J. et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell 41, 1152\u20131169.e1157 (2023).","journal-title":"Cancer Cell"},{"key":"54710_CR17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Polanski","year":"2020","unstructured":"Polanski, K. et al. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964\u2013965 (2020).","journal-title":"Bioinformatics"},{"key":"54710_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"54710_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36560-7","volume":"14","author":"Z Xun","year":"2023","unstructured":"Xun, Z. et al. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis. Nat. Commun. 14, 933 (2023).","journal-title":"Nat. Commun."},{"key":"54710_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41590-020-0733-2","volume":"21","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity. Nat. Immunol. 21, 1010\u20131021 (2020).","journal-title":"Nat. Immunol."},{"key":"54710_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi8800","volume":"6","author":"BL Horton","year":"2021","unstructured":"Horton, B. L. et al. Lack of CD8(+) T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer. Sci. Immunol. 6, eabi8800 (2021).","journal-title":"Sci. Immunol."},{"key":"54710_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e820 (2019).","journal-title":"Cell"},{"key":"54710_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26940-2","volume":"12","author":"AH Lee","year":"2021","unstructured":"Lee, A. H. et al. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nat. Commun. 12, 6938 (2021).","journal-title":"Nat. Commun."},{"key":"54710_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen, A. et al. Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat. Med. 29, 1389\u20131399 (2023).","journal-title":"Nat. Med"},{"key":"54710_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"54710_CR26","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","volume":"26","author":"N van Dijk","year":"2020","unstructured":"van Dijk, N. et al. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nat. Med 26, 1839\u20131844 (2020).","journal-title":"Nat. Med"},{"key":"54710_CR27","doi-asserted-by":"publisher","unstructured":"Niogret, J. et al. Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy. J. Immunother. Cancer 9, https:\/\/doi.org\/10.1136\/jitc-2020-002157 (2021).","DOI":"10.1136\/jitc-2020-002157"},{"key":"54710_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz6804","volume":"13","author":"W Yang","year":"2021","unstructured":"Yang, W. et al. A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Sci. Transl. Med. 13, eaaz6804 (2021).","journal-title":"Sci. Transl. Med."},{"key":"54710_CR29","doi-asserted-by":"publisher","unstructured":"Yang, M. et al. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. J. Immunother. Cancer 9, https:\/\/doi.org\/10.1136\/jitc-2020-001136 (2021).","DOI":"10.1136\/jitc-2020-001136"},{"key":"54710_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207\u2013215 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"54710_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo, S. K., Guo, M. G., Ji, A. L. & Khavari, P. A. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat. Rev. Genet. 22, 627\u2013644 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"54710_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med. 24, 994\u20131004 (2018).","journal-title":"Nat. Med."},{"key":"54710_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"54710_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"54710_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"54710_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"54710_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"54710_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21 (2020).","journal-title":"Genome Med."},{"key":"54710_CR39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"54710_CR40","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212\u201320217 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54710_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ijc.29864","volume":"138","author":"D Izumi","year":"2016","unstructured":"Izumi, D. et al. CXCL12\/CXCR4 activation by cancer-associated fibroblasts promotes integrin beta1 clustering and invasiveness in gastric cancer. Int J. Cancer 138, 1207\u20131219 (2016).","journal-title":"Int J. Cancer"},{"key":"54710_CR42","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41556-022-00918-8","volume":"24","author":"II Verginadis","year":"2022","unstructured":"Verginadis, I. I. et al. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat. Cell Biol. 24, 940\u2013953 (2022).","journal-title":"Nat. Cell Biol."},{"key":"54710_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","volume":"593","author":"MB Buechler","year":"2021","unstructured":"Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575\u2013579 (2021).","journal-title":"Nature"},{"key":"54710_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"54710_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","volume":"7","author":"T Liu","year":"2019","unstructured":"Liu, T., Zhou, L., Li, D., Andl, T. & Zhang, Y. Cancer-associated fibroblasts build and secure the tumor microenvironment. Front Cell Dev. Biol. 7, 60 (2019).","journal-title":"Front Cell Dev. Biol."},{"key":"54710_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43120-6","volume":"14","author":"D Pham","year":"2023","unstructured":"Pham, D. et al. Robust mapping of spatiotemporal trajectories and cell-cell interactions in healthy and diseased tissues. Nat. Commun. 14, 7739 (2023).","journal-title":"Nat. Commun."},{"key":"54710_CR47","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/1878-0261.12366","volume":"12","author":"Y Diao","year":"2018","unstructured":"Diao, Y. et al. Identification of novel GLI1 target genes and regulatory circuits in human cancer cells. Mol. Oncol. 12, 1718\u20131734 (2018).","journal-title":"Mol. Oncol."},{"key":"54710_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.17305\/bjbms.2018.2756","volume":"18","author":"AM Skoda","year":"2018","unstructured":"Skoda, A. M. et al. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn. J. Basic Med. Sci. 18, 8\u201320 (2018).","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"54710_CR49","first-page":"6555","volume":"61","author":"S Jacob","year":"2001","unstructured":"Jacob, S., Aguado, M., Fallik, D. & Praz, F. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 61, 6555\u20136562 (2001).","journal-title":"Cancer Res."},{"key":"54710_CR50","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568\u2013571 (2014).","journal-title":"Nature"},{"key":"54710_CR51","doi-asserted-by":"crossref","unstructured":"Nirmal, A. J. et al. The spatial landscape of progression and immunoediting in primary melanoma at single cell resolution. Cancer Discov 12, 1518\u20131541 (2022).","DOI":"10.1158\/2159-8290.CD-21-1357"},{"key":"54710_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"key":"54710_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41592-022-01480-9","volume":"19","author":"B Li","year":"2022","unstructured":"Li, B. et al. Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution. Nat. Methods 19, 662\u2013670 (2022).","journal-title":"Nat. Methods"},{"key":"54710_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307\u2013325 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"54710_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med 24, 994\u20131004 (2018).","journal-title":"Nat. Med"},{"key":"54710_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599, 673\u2013678 (2021).","journal-title":"Nature"},{"key":"54710_CR57","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01972","volume":"425","author":"DM Berman","year":"2003","unstructured":"Berman, D. M. et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846\u2013851 (2003).","journal-title":"Nature"},{"key":"54710_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0509-3","volume":"15","author":"A Hanna","year":"2016","unstructured":"Hanna, A. & Shevde, L. A. Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment. Mol. Cancer 15, 24 (2016).","journal-title":"Mol. Cancer"},{"key":"54710_CR59","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jamaoncol.2023.3323","volume":"9","author":"OE Emiloju","year":"2023","unstructured":"Emiloju, O. E. & Sinicrope, F. A. Neoadjuvant immune checkpoint inhibitor therapy for localized deficient mismatch repair colorectal cancer: A review. JAMA Oncol. 9, 1708\u20131715 (2023).","journal-title":"JAMA Oncol."},{"key":"54710_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00132-5","volume":"4","author":"SB Ye","year":"2020","unstructured":"Ye, S. B. et al. Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer. NPJ Precis Oncol. 4, 26 (2020).","journal-title":"NPJ Precis Oncol."},{"key":"54710_CR61","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41586-022-05046-9","volume":"608","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Live-seq enables temporal transcriptomic recording of single cells. Nature 608, 733\u2013740 (2022).","journal-title":"Nature"},{"key":"54710_CR62","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.cell.2022.04.003","volume":"185","author":"A Chen","year":"2022","unstructured":"Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 185, 1777\u20131792.e1721 (2022).","journal-title":"Cell"},{"key":"54710_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/science.abp9444","volume":"377","author":"X Wei","year":"2022","unstructured":"Wei, X. et al. Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration. Science 377, eabp9444 (2022).","journal-title":"Science"},{"key":"54710_CR64","doi-asserted-by":"publisher","unstructured":"Chen, A. et al. Single-cell spatial transcriptome reveals cell-type organization in the macaque cortex. Cell, https:\/\/doi.org\/10.1016\/j.cell.2023.06.009 (2023).","DOI":"10.1016\/j.cell.2023.06.009"},{"key":"54710_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"54710_CR66","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"54710_CR67","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"54710_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbacli.2015.03.003","volume":"3","author":"EA O\u2019Reilly","year":"2015","unstructured":"O\u2019Reilly, E. A. et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 3, 257\u2013275 (2015).","journal-title":"BBA Clin."},{"key":"54710_CR69","doi-asserted-by":"publisher","first-page":"D1053","DOI":"10.1093\/nar\/gkad933","volume":"52","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. STOmicsDB: A comprehensive database for spatial transcriptomics data sharing, analysis and visualization. Nucleic Acids Res 52, D1053\u2013D1061 (2024).","journal-title":"Nucleic Acids Res"},{"key":"54710_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi, K. et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39, 649\u2013661.e645 (2021).","journal-title":"Cancer Cell"},{"key":"54710_CR71","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997.e924 (2018).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54710-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54710-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54710-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T13:03:03Z","timestamp":1732626183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54710-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54710"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54710-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3322740\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Employees of BGI Research Hangzhou\/Shenzhen\/Chongqing have stock holdings in BGI. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10259"}}